Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

A Psychedelic & Nutraceutical Opportunity: A Boost for the Brain and Your Portfolio

A psilocybin mushroom, also known as a magic mushroom, offers infinite medical and scientific potential…from cognitive flexibility to potentially addressing clinical depression and eating disorders. There’s a lot we still don’t kn...

The Plant-Based / Psychedelics Hybrid Co. “Positioned For Growth”

(Click image to play video) M eet the Company and its CEO that’s positioning itself to be the premier cannabis commercialization extractor and manufacturing partner for functional psychedelic mushroom companies. Based on extensive extractio...

Opportunity Knocks as the Door Opens to Naturally-Derived Psychedelics

(CLICK IMAGE TO PLAY VIDEO) Stockhouse investors know that investment opportunities are opening up in the burgeoning psychedelics space. And while many are called, few are chosen. One company that looks to be the choice of many in the know is Filament Health Co...

Catching Up with the Company that’s Crafting the New Standard In Cannabis Extracts

When we last caught up with Adastra Labs Holdings Ltd. ( CSE.XTRX , OTC: XTXXF , Forum ) and their CEO Michael Forbes back in December , our Stockhouse audience got an in-depth look at one of the most innovative leaders in cannabis science. Stockhouse Media&CloseCu...

Solving the Hemp Extraction Problem created by the US Farm Bill

A CONVERSATION WITH NICK KIMBALL, PRESIDENT AND CEO, CASCADIA EXTRACTS, and AARON WILLIAMS, EXECUTIVE VICE PRESIDENT, CASCADIA EXTRACTS MOTIVATION What was your motivation to enter the hemp market in 2019? KIMBALL : Two years ago, the cannabis market ...

A Potential Psychedelic and COVID Therapy Play…All in One Stock

The global concern over the ongoing coronavirus pandemic isn’t going away and even the White House’s health advisor is concerned about what protection a potential vaccine may deliver…but…could there be an answer in a drug that already exists?...

A Unique Play in the Hungry US Hemp Market

(Image via Cascadia Extracts.) Utilizing high capacity CO 2 extraction equipment to tap into the extremely underserviced hemp market, Cascadia Extracts ( P. CASCADIA , Forum ) uses unique technology to take advantage of the significant benefits associated w...

HAVN Life Sciences: a biotech company developing technology-focused, data-driven psychedelic therapi

HAVN Life Sciences is a biotech company focused on psychedelic therapies. The Vancouver-based company develops technology-focused, data-driven, and medical-based solutions. Joining us here at the Top Line today is HAVN Life Sciences CEO, Tim Moore. Welcome back a...

A psychedelic renaissance

Fifty-three years after LSD was banned by the FDA, psychedelic drugs are making a comeback. Only instead of being the pills, mushrooms and acid tabs that helped college students to “turn on, tune in, drop out” Timothy Leary-style, today’...

Aurora Cannabis, EXMceuticals, Tilray - Cannabis development in Portugal

From the street to the clinic. Cannabis had the image of an illegal street drug in most rich countries since the prohibition in the USA in the 1930s. Although cannabis has been used as a medicinal plant for more than 1,000 years, the past decades have been marked by other phar...
1 2 3 4